| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/05/2007 | CA2273823C Polypeptides encoded by a human lipase-like gene, compositions and methods |
| 06/05/2007 | CA2214431C Human vegf-specific antisense oligonucleotides |
| 05/31/2007 | WO2007062342A1 Heterocyclic cetp inhibitors |
| 05/31/2007 | WO2007062193A1 Heterocycle-substituted 3-alkyl azetidine derivatives |
| 05/31/2007 | WO2007062175A2 Spiro-substituted tricyclic heterocycles cxcr3 antagonists |
| 05/31/2007 | WO2007061873A1 High-potency sweetener for weight management and compositions sweetened therewith |
| 05/31/2007 | WO2007061871A1 High-potency sweetener composition with phytosterol and compositions sweetened therewith |
| 05/31/2007 | WO2007061803A1 High-potency sweetener composition with c-reactive protein reducing substance and compositions sweetened therewith |
| 05/31/2007 | WO2007061795A1 Natural high-potency sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses |
| 05/31/2007 | WO2007061114A1 Pharmaceutical composition for prevention or treatment of neurogenic pain |
| 05/31/2007 | WO2007060992A1 Agent for preventing or improving metabolic syndrome or insulin-resistance syndrome |
| 05/31/2007 | WO2007060976A1 Novel ascochlorin derivative compounds and medicinal compositions containing the same |
| 05/31/2007 | WO2007060924A1 PROTECTING AGENT FOR PANCREATIC β-CELL |
| 05/31/2007 | WO2007060911A1 Aloe vera extract, process for production of aloe vera extract, and ameliorating agent for hyperglycemia |
| 05/31/2007 | WO2007060811A1 Process for production of fucoxanthinol |
| 05/31/2007 | WO2007060027A1 Isoquinoline et benzo[h]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of histamine h3 receptor |
| 05/31/2007 | WO2007059871A1 Hydroxy-substituted diphenylazetidinones for the treatment of hyperlipidaemia |
| 05/31/2007 | WO2007059569A1 Compositions and methods for treatment of diabetes |
| 05/31/2007 | WO2007042669A3 Derivatives of 4-amino-quinazoline, preparation method thereof and use of same in therapeutics |
| 05/31/2007 | WO2007042660A3 Substituted 1-amino-phthalzine derivatives, preparation and therapeutic use thereof |
| 05/31/2007 | WO2007042524A3 Treating diabetes using inhibitors of il-1 |
| 05/31/2007 | WO2007041077A3 Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 05/31/2007 | WO2007041052A3 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 05/31/2007 | WO2007040438A3 Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders |
| 05/31/2007 | WO2007037554A9 Adsorbent for advanced glycation endproducts |
| 05/31/2007 | WO2007037534A9 2-heteroaryl-substituted indole derivative |
| 05/31/2007 | WO2007030721A3 Processes for the preparation of (3r,4s)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((s)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe |
| 05/31/2007 | WO2007028632A3 Analogs of gastric inhibitory polypeptide as a treatment for age related decreased pancreatic beta cell function |
| 05/31/2007 | WO2007024863A2 Methods and formulations for modulating lyn kinase activity and treating related disorders |
| 05/31/2007 | WO2007019255A3 Salts of vildagliptin |
| 05/31/2007 | WO2007016600A3 Method of preserving the function of insulin-producing cells |
| 05/31/2007 | WO2007009080A3 Ppar [alpha/gamma] agonists and processes of preparing |
| 05/31/2007 | WO2007003957A3 Steroidal glycoside compounds as core 2 glcnac- t inhibitors |
| 05/31/2007 | WO2006136374A3 Use of gip and/or vitamin d3 analogues thereof for enhancing stem or progenitor cell differentiation into insulin producing cells |
| 05/31/2007 | WO2006110496A3 Activation of sodium potassium atpase |
| 05/31/2007 | WO2006110491B1 Complementary compositions to reduce blood glucose levels and treat diabetes |
| 05/31/2007 | US20070124837 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 05/31/2007 | US20070124825 Use of hepcidin as a regulator of iron homeostasis |
| 05/31/2007 | US20070123549 platelet activating factor aceylhydrolase inhibitors such as 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5-ethylpyrimidin-4-one; for treatment of atherosclerosis |
| 05/31/2007 | US20070123532 Piperazine derivatives |
| 05/31/2007 | US20070123530 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 05/31/2007 | US20070123529 Substituted biphenyl compounds |
| 05/31/2007 | US20070123528 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
| 05/31/2007 | US20070123453 Uses of melanocortin-4 receptor (mc4r) agonist peptides administered by continuous infusion |
| 05/31/2007 | US20070122493 Marine algae extract and glycosidase inhibitor containing the same |
| 05/31/2007 | US20070122475 Taste masking composition |
| 05/31/2007 | DE102005050376A1 Dicarbonsäure-Derivate und ihre Verwendung Dicarboxylic acid derivatives and their use |
| 05/31/2007 | DE102005049954A1 Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen Triazolopyridine derivatives as inhibitors of lipases and phospholipases |
| 05/31/2007 | CA2630818A1 Pharmaceutical composition for prevention or treatment of neurogenic pain |
| 05/31/2007 | CA2630655A1 Isoquinoline et benzo[h]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of histamine h3 receptor |
| 05/31/2007 | CA2630586A1 Compositions and methods for treatment of diabetes |
| 05/31/2007 | CA2630060A1 High-potency sweetener for weight management and compositions sweetened therewith |
| 05/31/2007 | CA2630054A1 High-potency sweetener composition with phytosterol and compositions sweetened therewith |
| 05/31/2007 | CA2630049A1 Natural high-potency sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses |
| 05/31/2007 | CA2602066A1 Aloe vera extract, method of producing aloe vera extract, and hyperglycemia improving agent |
| 05/30/2007 | EP1790728A2 Imaging, diagnosis and treatment of disease |
| 05/30/2007 | EP1790726A2 Modified and stabilized GDF propeptides and uses thereof |
| 05/30/2007 | EP1790725A2 Proteins named after FCTRX and nucleic acids encoding same |
| 05/30/2007 | EP1790655A2 Biologically active peptides |
| 05/30/2007 | EP1790652A1 Polycyclic guanine phosphodiesterase V inhibitors |
| 05/30/2007 | EP1790646A1 Isoquinoline und benzo[h]isoquinoline derivatives, their preparation and their therapeutical application as antagonists of histamine H3 receptor . |
| 05/30/2007 | EP1790641A1 Triazole derivative or salt thereof |
| 05/30/2007 | EP1790635A2 Processes for preparing amorphous fluvastatin sodium |
| 05/30/2007 | EP1790634A2 Fluvastatin sodium crystal form and processes for preparing it |
| 05/30/2007 | EP1790353A1 Combined use of a GLP-1 compound and a modulator of diabetic late complications |
| 05/30/2007 | EP1790346A2 Use of bile acid or bile salt fatty acid conjugates |
| 05/30/2007 | EP1790336A1 Composition for capsule film, capsule film, and capsule made with the same |
| 05/30/2007 | EP1789449A1 Anti-glycated cd59 antibodies and uses thereof |
| 05/30/2007 | EP1789407A2 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 05/30/2007 | EP1789403A1 N-(phenyl-oxazol-4-ylmethoxymethyl)-cyclohexyl.succinic acid amide derivatives and related compounds which are used as ppar-ligands (peroxisome proliferator activated receptors) for the treatment of hyperlipidaemie and diabetes |
| 05/30/2007 | EP1789402A1 2-{-3-2-(phenyl)-oxazol-4-ylmethoxymethyl!-cyclohexylmethoxy };-propionic acid derivatives used as ppar ligandes (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes |
| 05/30/2007 | EP1789396A1 Substituted phenylacetamides and their use as glucokinase activators |
| 05/30/2007 | EP1789386A1 Substituted indole compounds, their preparation and use in medicaments |
| 05/30/2007 | EP1789041A2 Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors |
| 05/30/2007 | EP1789026A2 Method for systemic bio-correction of an organism |
| 05/30/2007 | EP1709014B1 Antidiabetic oxazolidinediones and thiazolidinediones |
| 05/30/2007 | EP1509212B1 Novel chromium (iii) alpha amino acid complexes |
| 05/30/2007 | EP1496924A4 Treatment of gastroparesis |
| 05/30/2007 | EP1458672B1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha(ppar) |
| 05/30/2007 | EP1429763B1 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 05/30/2007 | EP1392291B1 Tripeptidyl peptidase inhibitors |
| 05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
| 05/30/2007 | EP1248615B1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 05/30/2007 | EP1221973B1 CD40 antagonist for treating psoriasis |
| 05/30/2007 | EP1177168B1 Caspase inhibitors and the use thereof |
| 05/30/2007 | EP1169037B1 Use of pioglitazone for improving ketosis and acidosis |
| 05/30/2007 | EP1062954B1 Use of itaconic acid for regulation of glycolytic metabolism |
| 05/30/2007 | EP1019010B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 05/30/2007 | EP0975754B1 Osteoprotegerin binding proteins and receptors |
| 05/30/2007 | EP0914605B1 Molecular model for vla-4 inhibitors |
| 05/30/2007 | EP0726954B2 Cytokine antagonists |
| 05/30/2007 | CN1972931A Drug for treating or preventing duplication of hypertension with serum hyperuricemia and/or hypercholesterolemia |
| 05/30/2007 | CN1972927A Compounds and methods for treating dyslipidemia |
| 05/30/2007 | CN1972926A Indole derivatives as histamine receptor antagonists |
| 05/30/2007 | CN1972918A 嘧啶衍生物 Pyrimidine derivatives |
| 05/30/2007 | CN1972897A Novel hexafluoroisopropanol derivatives |
| 05/30/2007 | CN1972715A Therapeutic agent for diabetes mellitus containing insulin resistance improving agent |
| 05/30/2007 | CN1972701A Appetite-suppressing compositions and methods |
| 05/30/2007 | CN1972698A Beta-hydroxy short to medium chain fatty acid polymer |
| 05/30/2007 | CN1972665A Injectable depot compositions and uses thereof |